What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod?: a discrete choice experiment survey from the SINS trial

Background: The SINS trial (Controlled Clinical Trials ISRCTN48755084; Eudract No. 2004-004506-24) is a randomised controlled trial evaluating long term success of excisional surgery vs. imiquimod 5% cream for low risk nodular and superficial basal cell carcinoma (BCC). The trial included a discre...

Full description

Bibliographic Details
Main Authors: Tinelli, Michela, Ozolins, Mara, Bath-Hextall, Fiona, Williams, Hywel C.
Format: Article
Language:English
Published: BioMed Central 2012
Online Access:http://eprints.nottingham.ac.uk/2903/
http://eprints.nottingham.ac.uk/2903/
http://eprints.nottingham.ac.uk/2903/
http://eprints.nottingham.ac.uk/2903/1/PrefsurveyOzolins.pdf